$115.22 +0.27 (0.24%) Celgene Corp - NASDAQ

Jan. 18, 2017 | 04:00 PM

Charts

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Key Statistics
Last Trade: 115.22
Trade Time: Jan 18 04:00 PM Eastern Daylight Time
Change: +0.27 (0.24%)
Prev Close: 114.95
Open: 115.10
Bid: 115.17
Ask: 115.22

Competitors

Ticker Name Volume % Change
BMY Bristol-Myers Squibb Company 6.64M -0.37%
AZN AstraZeneca Group plc 6.14M +0.11%
CGC.TO Canopy Growth Corporation 938.24K -2.00%
INVA Innoviva Inc. 778.28K -0.18%
IRWD Ironwood Pharmaceuticals, Inc. 674.81K +1.06%

CELG Stock Analysis

Partner Headlines

  1. Gilead 2017 Outlook Hamstrung On Hep C, But RBC Bullish On Amgen, Biogen

    Investors Business Daily | Jan. 18, 2017 | 16:33PM EST
  2. Trump Press Conference, Celgene, GW Pharma Lead Investing Action Plan

    Investors Business Daily | Jan. 10, 2017 | 16:08PM EST
  3. Celgene CEO: Drug-Pricing Debate Hinges On Incentives For Innovation

    Investors Business Daily | Jan. 10, 2017 | 13:26PM EST
  4. Stocks Trade Quietly Ahead Of Long Weekend; Biotechs Lead

    Investors Business Daily | Dec. 23, 2016 | 15:07PM EST
  5. Regeneron Likely To Jump On Amgen LDL-Buster, But Expectations Too High

    Investors Business Daily | Dec. 20, 2016 | 15:28PM EST
  6. Johnson & Johnson Boosted By Barron's Call For Rally

    TalkMarkets | Dec. 12, 2016 | 13:00PM EST
  7. Actelion Remains In M&A Spotlight, ASH Data In Focus

    TalkMarkets | Dec. 7, 2016 | 18:01PM EST
  8. S&P 500, Dow Notch All-Time Highs; Dave & Buster's Soars 19%

    Investors Business Daily | Dec. 7, 2016 | 16:07PM EST